Abstract
The effects of disrupting the muscarinic or nicotinic systems on short-term spatial memory were investigated using a delayed matching to position (DMTP) procedure. Rats were trained on the DMTP until stability and then divided into two groups: one group was implanted with an indwelling cannula aimed at the lateral ventricle. The cannulated group received injections of selective muscarinic antagonists (pirenzepine, M1; AFDX 116, M2; UH-AH 37, M1/M3) or hemicholinium-3 (a choline uptake inhibitor). The remaining animals were treated with conventional muscarinic antagonists (scopolamine, methyl scopolamine) or nicotinic channel blockers (mecamylamine, hexamethonium). Scopolamine, methyl scopolamine and UH-AH 37 disrupted all performance parameters in a non-specific but dose related manner. Pirenzepine disrupted accuracy in a delay, but not dose dependent manner, and exerted no other negative effects on performance. Hemicholinium-3-induced performance deficits showed some elements of effects seen following pirenzepine and scopolamine (delay dependent effects on accuracy, some negative effects on other motoric aspects of performance). AFDX 116 and hexamethonium had no significant effects on performance with respect to control. Mecamylamine reduced accuracy and increased response latencies at the highest dose tested. These data indicate that muscarinic antagonists are more effective at disrupting mnemonic performance than nicotinic blockers, and moreover, that distinct muscarinic receptors may have differential effects on cognitive performance.
Similar content being viewed by others
References
Andrews JS, Grützner M, Stephens DN (1992) The effects of cholinergic and non-cholinergic drugs on visual discrimination performance in rats. Psychopharmacology 106: 523–530
Angeli P, Brasili L, Cantalamessa, Marucci G, Wess J (1990) Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation. Naunyn-Schmiedeberg's Arch Pharmacol 342: 625–629
Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R (1988) Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 50: 1914–1923
Cole BJ, Klewer M, Jones GH, Stephens DN (1993) Contrasting effects of the competitive NMDA antagonist CPP and the noncompetitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats. Psychopharmacology 111: 465–471
Coyle JT, Price DL, Delong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 217:1184–1190
Deacon RMJ (1991) Pharmacological studies of a rat spatial delayed nonmatch-to-sample task as an animal model of dementia. Drug Dev Res 24: 67–79
Doods HN, Quirion R, Mihm G, Engel W, Rudolf K, Entzeroth M, Schiavi GB, Ladinsky H, Bechtel WD, Ensinger HA, Mendla KD, Eberlein W (1993) Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology. Life Sci 52: 497–503
Dunnett SB (1985) Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology 87: 357–363
Dunnett SB (1990) Role of prefrontal cortex and striatal output systems in short-term memory deficits associated with ageing, basal forebrain lesions, and cholinergic-rich grafts. Can J Psychol 44: 210–232
Dunnett SB, Rogers DC, Jones GH (1989) Effects of nuclues basalis magnocellularis lesions in rats on delayed matching and non-matching to position tasks. Eur J Neurosci 1: 395–406
Dunnett SB, Wareham AT, Torres EM (1990) Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats. NeuroReport 1: 61–64
Elrod K, Buccafusco JJ, Jackson WJ (1988) Nicotine enhances delayed matching-to-sample performance by primates. Life Sci 43: 277–287
Freedman SB, Dawson GR, Iversen LL, Baker R, Hargreaves RJ (1993) The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo. Life Sci 52: 489–495
Freeman JJ, Macri JR, Choi RL, Jenden DJ (1979) Studies on the behavioral and biochemical effects of hemicholinium in vivo. J Pharmacol Exp Ther 210: 91–97
Gower AJ (1987) Effects of acetylcholine agonist and antagonist on yawning and analgesia in the rat. Eur J Pharmacol 139: 79–89
Hagan JJ, Morris RGM (1988) The cholinergic hypothesis of memory: a review of animal experiments. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, Vol 20. Plenum, NY, pp 237–323
Hagan JJ, Jansen JHM, Broekkamp CLE (1987) Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine. Psychopharmacology 93: 470–476
Hagan JJ, van der Heijden B, Broekkamp CLE (1988) The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine. Naunyn-Schmiedeberg's Arch Pharmacol 338: 476–483
Hagan JJ, Jansen JHM, Broekkamp CLE (1989) Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics. Psychopharmacology 98: 347–356
Hunter AJ, Roberts FF (1988) The effect of pirenzepine on spatial learning in the Morris water maze. Pharmacol Biochem Behav 30: 519–523
Lambrecht G, Feifell R, Forth B, Strohmann C, Tacke R, Mutschler E (1988)p-Fluoro-hexahydro-siladifenidol: the first M2B-selective muscarinic antagonist. Eur J Pharmacol 152: 193–194
Levey AI (1993) Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52: 441–448
Levin ED, Castonguay M, Ellinson GD (1987) Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav Neural Biol 48: 206–212
Levin ED, McGurk SR, South D, Butcher LL (1989) Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. Behav Neural Biol 51: 270–277
Mash DC, Flynn DD, Potter LT (1985) Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228: 1115–1117
Messer WS, Bohnett M, Stibbe J (1990) Evidence for a preferential involvement of M1 muscarinic receptors in representational memory. Neurosci Lett 116: 184–189
Moore H, Dudchenko P, Comer KS, Bruno JP, Sarter M (1992) Central versus peripheral effects of muscarinic antagonists: the limitations of quaternary ammonium derivatives. Psychopharmacology 108: 241–243
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores. BMJ 2: 1457–1459
Ridley RM, Barratt NG, Baker HF (1984) Cholinergic learning deficits in the marmoset produced by scopolamine and icv hemicholinium. Psychopharmacology 83: 340–345
Ridley RM, Baker HF, Drewett B (1987) Effects of arecoline and pilocarpine on learning ability in marmosets pretreated with hemicholinium-3. Psychopharmacology 91: 512–514
Rusted JM, Eaton-Williams P, Warburton DM (1991) A comparison of the effects of scopolamine and diazepam on working memory. Psychopharmacology 105: 442–445
Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychol 154: 797–800
Sahgal A (1987) Contrasting effects of vasopressin, desglycinamide-vasopressin and amphetamine on a delayed matching to position task in rats. Psychopharmacology 93: 243–249
Sahgal A, Keith A, Lloyd S (1990) Effects of nicotine, oxotremorine and 9-amino 1,2,3,4-tetrahydroacridine (tacrine) on matching and non-matching to position in rats: no evidence for mnemonic enhancement. J Psychopharmacol 4: 210–218
Sala M, Braida D, Calcaterra P, Leone MP, Comotti FA, Gianola S, Gori E (1991) Effect of centrally administered atropine and pirenzepine on radial arm maze performance in the rat. Eur J Pharmacol 194: 45–49
Sarter M, Hagan J, Dudchenko P (1992a) Behavioral screening for cognition enhancers: from indiscriminate to valid testing: part I. Psychopharmacology 107: 144–159
Sarter M, Hagan J, Dudchenko P (1992b) Behavioral screening for cognition enhancers: from indiscriminate to valid testing: part II. Psychopharmacology 107: 461–473
Spencer DG Jr, Emmett-Oglesby MW (1985) Parallel processing strategies in the application of microcomputers to the behavioural laboratory. Behav Res Methods Instr 17: 294–300
Stewart BR, Jenner P, Marsden CD (1989) Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour. Psychopharmacology 97: 228–234
Van Haaren F, Van Hest A (1989) The effects of scopolamine and methylscopolamine on visual and auditory discriminations in male and female wistar rats. Pharmacol Biochem Behav 32: 707–710
Van Hest A, Stroet J, Van Haaren F, Feenstra M (1990) Scopolamine differentially disrupts the behaviour of male and female wistar rats in a delayed nonmatching to position procedure. Pharmacol Biochem Behav 35: 903–909
Viscardi AP, Heise GA (1986) effects of scopolamine on components of delayed response performance in the rat. Pharmacol Biochem Behav 25: 633–639
Wess J, Lambrecht G, Mutschler E, Brann MR, Dorje F (1991) Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations. Br J Pharmacol 102: 246–250
Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL, Kellar KJ (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 371: 146–151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andrews, J.S., Jansen, J.H.M., Linders, S. et al. Effects of disrupting the cholinergic system on short-term spatial memory in rats. Psychopharmacology 115, 485–494 (1994). https://doi.org/10.1007/BF02245572
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245572